522 results on '"Martelli, Alma"'
Search Results
152. INVOLVEMENT OF KV7 POTASSIUM CHANNELS IN THE EFFECTS OF HYDROGEN SULPHIDE ON VASCULAR SMOOTH MUSCLE
153. ROLE OF MITOCHONDRIAL BK POTASSIUM CHANNELS IN THE CARDIOPROTECTIVE EFFECTS OF FLAVONOIDS AGAINST ISCHEMIA/REPERFUSION INJURY
154. Cardiovascular effects of a new NO-releasing Coxib derivative
155. Hydrogen sulfide inhalation ameliorates allergen induced airway hypereactivity by modulating mast cell activation
156. Inhibitors of the renal outer medullary potassium channel: a patent review
157. Different patterns of H2S/NO cross-talk in the control of the coronary vascular bed under normotensive or hypertensive conditions
158. Isothiocyanates and inhibition of mast cell degranulation: Is hydrogen sulfide the real player?
159. HYDROGEN SULPHIDE: BIOLOGICAL FUNCTIONS, PHARMACOLOGICAL IMPLICATIONS AND NEW OPPORTUNITIES FOR DRUG DISCOVERY
160. ANTI-ISCHEMIC PROPERTIES OF ORIGINAL SPIRO-CYCLIC BENZOPYRAN DERIVATIVES: INVOLVEMENT OF THE CARDIAC MITO-KATP CHANNEL
161. Pharmacological characterization of the vascular effects of aryl isothiocyanates: is hydrogen sulfide the real player?
162. Hydrogen sulfide releasing capacity of natural isothiocyanates: is it a reliable explanation for the multiple biological effects of Brassicaceae?
163. A NOVEL NITRIC OXIDE RELEASING ANTI-DIABETIC DUAL DRUG: FROM THE DESIGN TO THE CHARACTERIZATION OF THE PHARMACOLOGICAL PROFILE
164. Spiro-benzopyran structure: a new scaffold for cardioprotection
165. EFFECTS OF TSPO-LIGANDS ON MITOCHONDRIAL VOLUME AND MITOCHONDRIAL MEMBRANE POTENTIAL
166. ANTI-ISCHEMIC PROPERTIES OF A NEW SPIRO-CYCLIC BENZOPYRAN ACTIVATOR OF CARDIAC MITOCHONDRIAL ATP-SENSITIVE POTASSIUM CHANNELS
167. Synthesis and biological evaluation of 5-membered spiro heterocycle-benzopyran derivatives against myocardial ischemia
168. Pharmacodynamic hybrids with insulin secretagogue and NO-Donor activity
169. Nitric Oxide Releasing and Hypoglycaemic Properties of a Glibenclamde-Related Pharmacodynamic Hybrid
170. A NEW NITRIC OXIDE RELEASING ANTI-DIABETIC HYBRID DRUG: FROM THE DESIGN TO THE PHARMACOLOGICAL CHARACTERIZATION
171. New pharmacodynamic hybrids endowed of insuline secretagogue and NO-donor activities
172. (+/-)-NARINGENIN AS KCA 1.1 CHANNEL OPENER IN VASCULAR SMOOTH MUSCLE CELLS
173. Anti-ischemic properties of new spiro-morpholine benzopyrane derivatives, potential activators of mitochondrial atp-sensitive potassium channel, on isolated rat hearts
174. Synthesis and pharmacological activity of new nitric-oxide-donating antihypertensive drugs (NO-Sartans)
175. Pharmacological study on the cardiovascular activity of no-sartans, pharmacodynamic hybridsexhibiting at1-antagonist and no-donor properties
176. 1,5-Diarylsubstituted 1,2,3-triazoles as potential potassium channels activators. VI
177. Hydrogen Sulfide Releasing Capacity of Natural Isothiocyanates: Is It a Reliable Explanation for the Multiple Biological Effects of Brassicaceae?
178. NO-sartans: new class of potential cardiovascular drugs
179. NO-sartans: new class of potential cardiovascular drugs
180. Arylthioamides as H2S Donors: l-Cysteine-Activated Releasing Properties and Vascular Effects in Vitro and in Vivo.
181. NSAID-Induced Enteropathy: Are the Currently Available Selective COX-2 Inhibitors All the Same?
182. Arylthioamides as H2S Donors: l-Cysteine-Activated Releasing Properties and Vascular Effects in Vitro and in Vivo
183. Correction to Novel Analgesic/Anti-Inflammatory Agents: 1,5-Diarylpyrrole Nitrooxyalkyl Ethers and Related Compounds as Cyclooxygenase-2 Inhibiting Nitric Oxide Donors
184. 1,4-Benzothiazine ATP-Sensitive Potassium Channel Openers: Modifications at the C-2 and C-6 Positions
185. Novel Analgesic/Anti-Inflammatory Agents: 1,5-Diarylpyrrole Nitrooxyalkyl Ethers and Related Compounds as Cyclooxygenase-2 Inhibiting Nitric Oxide Donors
186. The novel H2 S donor 4-carboxy-phenyl isothiocyanate inhibits mast cell degranulation and renin release by decreasing intracellular calcium.
187. Expression and function of Kv7.4 channels in rat cardiac mitochondria: possible targets for cardioprotection.
188. 1,2,3-Triazol-carboxanilides and 1,2,3-triazol-( N-benzyl)-carboxamides as BK-potassium channel activators. XII
189. Novel Analgesic/Anti-Inflammatory Agents: Diarylpyrrole Acetic Esters Endowed with Nitric Oxide Releasing Properties
190. ChemInform Abstract: Synthesis and Biological Evaluation of 5-Membered Spiro Heterocycle-Benzopyran Derivatives Against Myocardial Ischemia.
191. Hydrogen sulphide: novel opportunity for drug discovery
192. Effects of KATPopeners on the QT prolongation induced by HERG-blocking drugs in guinea-pigs
193. Enantioselectivity in Cardioprotection induced by (S)- (−)-2,2-Dimethyl-N-(4′-acetamido-benzyl)-4-spiromorpholone-chromane
194. Pharmacodynamic Hybrids Coupling Established Cardiovascular Mechanisms of Action with Additional Nitric Oxide Releasing Properties
195. Spirocyclic Benzopyran-Based Derivatives as New Anti-ischemic Activators of Mitochondrial ATP-Sensitive Potassium Channel
196. N6-1,3-Diphenylurea derivatives of 2-phenyl-9-benzyladenines and 8-azaadenines: Synthesis and biological evaluation as allosteric modulators of A2A adenosine receptors
197. Novel 1,4-Benzothiazine Derivatives as Large Conductance Ca2+-Activated Potassium Channel Openers
198. New Benzopyran-Based Openers of the Mitochondrial ATP-Sensitive Potassium Channel with Potent Anti-Ischemic Properties
199. New NO-Releasing Pharmacodynamic Hybrids of Losartan and Its Active Metabolite: Design, Synthesis, and Biopharmacological Properties
200. Benzoyl and/or Benzyl Substituted 1,2,3-Triazoles as Potassium Channel Activators. Part 8.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.